Article Details

Pfizer/Valneva Lyme Disease Vaccine Candidate Enters Phase II

Retrieved on: 2021-03-09 13:07:30

Tags for this article:

Click the tags to see associated articles and topics

Pfizer/Valneva Lyme Disease Vaccine Candidate Enters Phase II. View article details on hiswai:

Excerpt

Pfizer's stock has declined 5.6% so far this year compared with 1.3% decrease for the industry. Pfizer boasts a thriving vaccines business, accounting for ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up